SPECT with DaTscan may boost differential diagnosis of dementia

03/19/2013 | MedPage Today (free registration)

SPECT imaging using the radioactive iodine-based tracer DaTscan helped differentiate cases of Lewy body dementia and non-amnestic mild cognitive impairment from Alzheimer's disease and amnestic MCI, according to findings presented at a neurology meeting. DaTscan was approved last year as an imaging agent for the differentiation of Parkinson's disease from essential tremor.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ
Chief Executive Officer
UCare Minnesota
Minneapolis, MN
Program Coordinator/Lecturer for the Regulatory Science program
Johns Hopkins University
Washington, DC